A group of academics is arguing that countries seeking access to a groundbreaking HIV prevention drug from Gilead Sciences ...

“I am Medicaid, don’t cut me! I am Medicaid, don’t cut me!” The chants echoed across the grass in front of the Capitol ...

Biotech stocks and the broader markets snapped higher Wednesday after President Trump announced a 90-day pause on reciprocal tariffs for all countries except China, backing down from a trade policy ...

STATUS List features 50 influential people shaping the future of biotech, medicine, health care, policy, and health tech.

The National Cancer Institute’s Investigational New Drug program facilitates collaboration, not collusion, with industry for ...

This isn’t just an animal health crisis — it’s a risk to public health. When animals consume foods containing live virus, ...

A small office that produced data on alcohol-related deaths and harms, and worked on policies to reduce them, has been ...

Robert F. Kennedy Jr. has shown "complete disregard for science” and should resign, says Georges Benjamin of the American ...

The Division of Policy Development in the Office of Generic Drug Policy, which was created more than a decade ago, was ...

The paper analyzed data from a CDC database that is different from the Pregnancy Risk Assessment Monitoring System hit hard ...

Low-income Americans could soon have new constraints on how they shop for food under bills in more than a dozen states.

On his MAHA Tour, Robert F. Kennedy Jr. plays up victories in fluoridation and nutrition, plays down measles while away from ...